Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
We previously identified autoantibodies to the endocytic-associated protein Huntingtin-interacting protein 1-related (HIP1R) in diffuse large B-cell lymphoma (DLBCL) patients. HIP1R regulates internalization of cell surface receptors via endocytosis, a process relevant to many therapeutic strategies...
Main Authors: | Wong, K, Gascoyne, D, Brown, P, Soilleux, E, Snell, C, Chen, H, Lyne, L, Lawrie, C, Gascoyne, R, Pedersen, L, Møller, M, Pulford, K, Murphy, D, Green, T, Banham, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
by: Wong, K, et al.
Published: (2014) -
FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
by: Wong, K, et al.
Published: (2016) -
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
by: Brown, P, et al.
Published: (2015) -
The significance of FOXP1 in diffuse large B-cell lymphoma
by: Gascoyne, D, et al.
Published: (2016) -
N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
by: Brown, P, et al.
Published: (2016)